Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025
Cytek Biosciences shares rose about 9% to $4.99 Friday afternoon, appearing on Nasdaq’s notable movers list as the broader market declined. The stock has gained over 20% since late October, boosted by recent industry recognition, product awards, and a new collaboration highlighted in a sector report.
